Patent · US Active

Substituted pyrazolo[3,4-D]pyrimidines as kinase antagonists

US7585868B2 · kind B2 · utility

98Cited by
46References
16Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 4, 2007
Grant dateSep 8, 2009
Priority date
Expiry dateApr 4, 2027

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D471/04
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention provides novel compounds that can be used as antagonists of a lipid kinase such as a PI3 kinase, protein tyrosine kinase, and/or protein serine-threonine kinases such as mTOR. The present invention also provides methods of using the compounds for treating various disease conditions. The compounds include those having the formula:wherein the R1, R2 and R36 are as defined herein.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.